Frontiers in Medicine Ebook: Public-Private Partnerships as drivers of innovation in healthcare

Hilde Stevens, Michel Goldman

Front. Med., Nov 2019, ISSN 1664-8714 | ISBN 978-2-88963-111-7 | DOI 10.3389/978-2-88963-111-7

Abstract:

Multi-stakeholder collaborations involving partners from public and private sectors are essential to address global health challenges and to move precision medicine forward. This eBook assembles a collection of papers which either illustrate recent achievements or discuss new perspectives offered by public-private partnerships in healthcare.

Page 7 to 13:
The european Lead Factory: A Blueprint for Public–Private Partnerships in early Drug Discovery
Anna Karawajczyk, Kristina M. Orrling, Jon S. B. de Vlieger, Ton Rijnders and Dimitrios Tzalis

Want to know more about this publication?
Contact our scientists

Medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

custom chemical services

Custom Synthesis

We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…

Looks interesting?

As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
Scroll to Top